|
- Homepage: The Kelso Difference | Kelso
Kelso is a North American-focused middle market private equity firm Kelso was founded on the principles of partnership and alignment of interest espoused by Louis Kelso, the inventor of the Employee Stock Ownership Plan (or ESOP)
- News - Kelso
Kelso is pleased to announce that we completed an investment in Valenz in June 2023 Valenz provides mission-critical payment integrity and cost containment solutions to counteract rising costs of healthcare for small and mid-sized employers Valenz is led by CEO Rob Gelb and employs a team of ~300 employees nationwide
- Foundation Consumer Healthcare - Kelso
Over-the-counter (“OTC”) pharmaceutical platform that owns market leading brands including Plan B One-Step (emergency contraceptive), Theravent (snoring relief), Campho-Phenique (cold sore relief), St Joseph (low-dose aspirin), Bronkaid (asthma relief), and Neo-Synephrine (nasal decongestant)
- Investments - Kelso
Kelso identified a substantial opportunity for value creation by consolidating the fragmented salvage vehicle auction sector, including by combining IAAI with the salvage operations of ADESA
- Our Approach - Kelso
We utilize the cumulative experience of the Kelso professionals, as well as our extensive network of industry experts, to provide our partners with strategic insights and to help our management teams drive value creation
- Kelso Investor Portal
Terms Of Use | Privacy Policy | Copyright © 2025 by Kelso Company
- All Investments - Kelso
Investment - Inovar J S Held KAR Auction Services Kelso Overland Kerotest Manufacturing Key Components Kilsby-Roberts
- Premia Raises $510 million In Initial Capital From Leading . . . - Kelso
Kelso benefits from a successful investment track record, a long-tenured and stable investing team, and a reputation as a preferred partner to management teams and corporates Since 1980, Kelso has raised a total of nine private equity funds, representing approximately $12 billion of capital, and has made 120 investments
|
|
|